Skip to main content
. 2017 Oct 17;5:76. doi: 10.1186/s40425-017-0282-x

Table 2.

Adverse events in patients receiving RT plus pembrolizumab (n = 21)

Adverse Event Grade 1 Grade 2 Grade 3 Grade 4
Diarrhea/nausea 3
Pruritis/Rash 2 1
Cardiopulmonary
Hepatitis
 Fatigue 14
 Headache 2
 CNS bleeding 1
(from treated BM)
 Seizure 1 1
 Cognitive change 2 1
 Neurologic dysfunction 1 1
 Perilesional Edema 3 1